Ceryvyn Therapeutics-ADRCYVNY
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 11 institutions reported holding Ceryvyn Therapeutics-ADR (CYVNY) in their 13F filings, up 4 from Q3 2024. 5 opened new positions and 2 sold out. The largest holders were Regal Partners Ltd ($11.4M), Baker Bros. Advisors LP ($8.5M) and HSBC Holdings PLC ($556K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ceryvyn Therapeutics-ADR
- Filed as
- OPTHEA LTD (Q4 2024)
- CUSIP
- 68386J208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $739K |
| Exits | 2 | $235K |
All 13F filers, Q3 2024 → Q4 2024: 223,286 shares bought and 62,523 shares sold, net +160,763 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Regal Partners Ltd | 1.16% | No change | 2,907,403 | $11.4M |
| Baker Bros. Advisors LP | 0.09% | No change | 2,173,622 | $8.5M |
| HSBC Holdings PLC | 0.00% | New | 142,515 | $556K |
| Millennium Management | 0.00% | Reduce -9.3% | 61,101 | $241K |
| UBS Group AG | 0.00% | Add +1439.2% | 36,757 | $144K |
| Citadel Advisors | 0.00% | New | 19,998 | $79K |
| Twin Lakes Capital Management, LLC | 0.05% | No change | 19,806 | $78K |
| Susquehanna International Group, LLP | 0.00% | New | 12,311 | $49K |
| Old Mission Capital LLC | 0.00% | New | 10,728 | $42K |
| Abc Arbitrage SA | 0.01% | — | 10,216 | $40K |
| Morgan Stanley | 0.00% | New | 3,365 | $13K |
"% of holder's portfolio" is CYVNY's weight in each manager's 13F, not the share of Ceryvyn Therapeutics-ADR the manager owns.